Precursor B-lymphoblastic transformation of grade I follicle center lymphoma following rituximab therapy.
Follows
G A
GA
McVerry
A
A
Owen
R G
RG
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation; D016393:Lymphoma, B-Cell; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab